NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

血糖自我檢測的全球市場:2025年前的各類型,頻率,各產品,各終端用戶,不同地區的預測和機會

Global Self-monitoring Blood Glucose Market By Type, By Frequency, By Product, By End-User, By Region, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 934762
出版日期 內容資訊 英文 118 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

血糖自我檢測的全球市場:2025年前的各類型,頻率,各產品,各終端用戶,不同地區的預測和機會 Global Self-monitoring Blood Glucose Market By Type, By Frequency, By Product, By End-User, By Region, Forecast & Opportunities, 2025
出版日期: 2020年05月01日內容資訊: 英文 118 Pages
簡介

本報告提供全球蛋白質體學市場調查,提供各地區市場展望,市場力學,主要的趨勢,競爭情形等資訊,並提供策略性建議。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 客戶的迴響

第5章 全球血糖自我檢測市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型(1型,2型,高血糖,低血糖)
    • 各頻率(1,4,其他)
    • 各產品(血糖儀,軟體,試驗帶,採血針)
    • 各終端用戶(醫院,個人保養品)
    • 各公司(2019)
    • 各地區
  • 市場魅力指數

第6章 亞太地區的血糖自我檢測市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型
    • 各頻率
    • 各產品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 亞太地區:各國分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 新加坡
    • 澳洲

第7章 歐洲的血糖自我檢測市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型
    • 各頻率
    • 各產品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 歐洲:各國分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 俄羅斯
    • 西班牙

第8章 北美的血糖自我檢測市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型
    • 各頻率
    • 各產品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 北美:各國分析
    • 美國
    • 墨西哥
    • 加拿大

第9章 南美的血糖自我檢測市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型
    • 各頻率
    • 各產品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 南美:各國分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章 中東和非洲的血糖自我檢測市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型
    • 各頻率
    • 各產品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 中東·非洲地區:各國分析
    • 南非的血糖檢測市場自我監視
    • 沙烏地阿拉伯的血糖自我檢測市場預測
    • UAE血糖自我檢測市場展望

第11章 市場動態

  • 促進因素
  • 課題

第12章 市場趨勢

第13章 競爭情形

  • 競爭的展望
  • 主要企業的簡介
    • PHC Holdings Corporation
    • Roche
    • LifeScan
    • Arkray
    • Ascensia Diabetes Care
    • Agamatrix
    • Bionime Corporation
    • Sanofi
    • Dexcom
    • Medtronic
    • Nipro Diagnostics
    • B. Braun
    • Becton Dickinson
    • Trividia Health
    • Rossmax
    • Allmedicus
    • Nova Biomedical
    • Sinocare
    • Morepen Laboratories
    • I-Sens

第14章 策略性建議

第15章 免責聲明

目錄
Product Code: 4607

Global self-monitoring blood glucose market is expected to grow at a formidable rate during the forecast period owing to various growth factors such as increasing number of diabetic patients around the world, sedentary lifestyles, surge in need for faster and safer diagnosis & treatment of diabetes. Furthermore, technological innovations, early detection of hypo/hyperglycemic diabetes, increasing awareness about diabetes care and rise in obese population is driving the growth of global self-monitoring blood glucose market. Additionally, aging population is also acting as a major driver for the growth of the self-monitoring blood glucose devices market as it is more prone to diabetes and illness due to their low immunity levels. Moreover, self-monitoring blood glucose devices are used to monitor a patient's blood glucose level. They find wide application as they are easy-to-use and enable people to monitor their blood glucose levels irrespective of their location. However, the self-monitoring blood glucose market also faces some restraints. The capital required for R&D activities involved in the development of self-monitoring devices is high, which acts as a barrier for companies willing to enter the market.

The global self-monitoring blood glucose market is segmented based type, frequency, product, end-user and region. Based on product, the market is segmented into glucometer, software, test strips and lancet. Test strips dominated the self-monitoring blood glucose market and are expected to hold their dominance in the coming years as they are cost-effective and are also used for testing ketone levels in the blood.

Based on end-user, the market is segmented into hospitals and personal care. Among these two, the personal care segment is estimated to account for the largest share of the global blood glucose monitoring system market until 2025. The reason behind this is increasing awareness among people about regular monitoring of glucose levels.

Major players operating in the global self-monitoring blood glucose market include PHC Holdings Corporation, Roche, LifeScan, Arkray,Ascensia Diabetes Care, Agamatrix, Bionime Corporation, Sanofi, Dexcom, Medtronic, Nipro Diagnostics, B. Braun, Becton Dickinson, Trividia Health, Rossmax, Allmedicus, Nova Biomedical, Sinocare, Morepen Laboratories, I-Sens and others. There is a moderate threat to new players entering the self-monitoring blood glucose market, as every new player needs to abide by the stringent and mandatory regulatory standards set by the governments.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and estimate the market size of global self-monitoring blood glucose market from 2015 to 2018.
  • To estimate and forecast the market size of global self-monitoring blood glucose market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global self-monitoring blood glucose market based on type, frequency, product, end-user, company and regional distribution.
  • To identify dominant region or segment in the global self-monitoring blood glucose market.
  • To identify drivers and challenges for global self-monitoring blood glucose market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global self-monitoring blood glucose market.
  • To conduct pricing analysis for global self-monitoring blood glucose market.
  • To identify and analyze the profile of leading players operating in global self-monitoring blood glucose market.
  • To identify key sustainable strategies adopted by market players in global self-monitoring blood glucose market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of self-monitoring blood glucose device manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the self-monitoring blood glucose devices manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the materials used in manufacturing of self-monitoring blood glucose devices, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global self-monitoring blood glucose market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Self-monitoring blood glucose device manufacturers, suppliers, distributors and other stakeholders
  • Hospital centers including ASCs, clinics
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to self-monitoring blood glucose devices
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as blood bag manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global self-monitoring blood glucose market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Type:

Type 1

Type 2

Hyperglycemia

Hypoglycemia

  • Market, By Frequency:

One

Four

Others

  • Market, By Product:

Glucometer

Software

Test Strips

Lancet

  • Market, By End-User:

Hospitals

Personal Care

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global self-monitoring blood glucose market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Self-monitoring Blood Glucose Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Type 1, Type 2, Hyperglycemia, Hypoglycemia)
    • 5.2.2. By Frequency (One, Four, Others)
    • 5.2.3. By Product (Glucometer, Software, Test Strips, Lancet)
    • 5.2.4. By End-User (Hospital, Personal Care)
    • 5.2.5. By Company (2019)
    • 5.2.6. By Region
  • 5.3. Market Attractiveness Index

6. Asia-Pacific Self-monitoring Blood Glucose Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Frequency
    • 6.2.3. By Product
    • 6.2.4. By End-User
    • 6.2.5. By Country
  • 6.3. Market Attractiveness Index
  • 6.4. Asia-Pacific: Country Analysis
    • 6.4.1. China Self-monitoring Blood Glucose Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Type
        • 6.4.1.2.2. By Frequency
        • 6.4.1.2.3. By Product
        • 6.4.1.2.4. By End-User
    • 6.4.2. India Self-monitoring Blood Glucose Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Type
        • 6.4.2.2.2. By Frequency
        • 6.4.2.2.3. By Product
        • 6.4.2.2.4. By End-User
    • 6.4.3. Japan Self-monitoring Blood Glucose Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Type
        • 6.4.3.2.2. By Frequency
        • 6.4.3.2.3. By Product
        • 6.4.3.2.4. By End-User
    • 6.4.4. South Korea Self-monitoring Blood Glucose Market Outlook
      • 6.4.4.1. Market Size & Forecast
        • 6.4.4.1.1. By Value
      • 6.4.4.2. Market Share & Forecast
        • 6.4.4.2.1. By Type
        • 6.4.4.2.2. By Frequency
        • 6.4.4.2.3. By Product
        • 6.4.4.2.4. By End-User
    • 6.4.5. Singapore Self-monitoring Blood Glucose Market Outlook
      • 6.4.5.1. Market Size & Forecast
        • 6.4.5.1.1. By Value
      • 6.4.5.2. Market Share & Forecast
        • 6.4.5.2.1. By Type
        • 6.4.5.2.2. By Frequency
        • 6.4.5.2.3. By Product
        • 6.4.5.2.4. By End-User
    • 6.4.6. Australia Self-monitoring Blood Glucose Market Outlook
      • 6.4.6.1. Market Size & Forecast
        • 6.4.6.1.1. By Value
      • 6.4.6.2. Market Share & Forecast
        • 6.4.6.2.1. By Type
        • 6.4.6.2.2. By Frequency
        • 6.4.6.2.3. By Product
        • 6.4.6.2.4. By End-User

7. Europe Self-monitoring Blood Glucose Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Frequency
    • 7.2.3. By Product
    • 7.2.4. By End-User
    • 7.2.5. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. Europe: Country Analysis
    • 7.4.1. France Self-monitoring Blood Glucose Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Type
        • 7.4.1.2.2. By Frequency
        • 7.4.1.2.3. By Product
        • 7.4.1.2.4. By End-User
    • 7.4.2. Germany Self-monitoring Blood Glucose Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Type
        • 7.4.2.2.2. By Frequency
        • 7.4.2.2.3. By Product
        • 7.4.2.2.4. By End-User
    • 7.4.3. United Kingdom Self-monitoring Blood Glucose Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Type
        • 7.4.3.2.2. By Frequency
        • 7.4.3.2.3. By Product
        • 7.4.3.2.4. By End-User
    • 7.4.4. Italy Self-monitoring Blood Glucose Market Outlook
      • 7.4.4.1. Market Size & Forecast
        • 7.4.4.1.1. By Value
      • 7.4.4.2. Market Share & Forecast
        • 7.4.4.2.1. By Type
        • 7.4.4.2.2. By Frequency
        • 7.4.4.2.3. By Product
        • 7.4.4.2.4. By End-User
    • 7.4.5. Russia Self-monitoring Blood Glucose Market Outlook
      • 7.4.5.1. Market Size & Forecast
        • 7.4.5.1.1. By Value
      • 7.4.5.2. Market Share & Forecast
        • 7.4.5.2.1. By Type
        • 7.4.5.2.2. By Frequency
        • 7.4.5.2.3. By Product
        • 7.4.5.2.4. By End-User
    • 7.4.6. Spain Self-monitoring Blood Glucose Market Outlook
      • 7.4.6.1. Market Size & Forecast
        • 7.4.6.1.1. By Value
      • 7.4.6.2. Market Share & Forecast
        • 7.4.6.2.1. By Type
        • 7.4.6.2.2. By Frequency
        • 7.4.6.2.3. By Product
        • 7.4.6.2.4. By End-User

8. North America Self-monitoring Blood Glucose Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Frequency
    • 8.2.3. By Product
    • 8.2.4. By End-User
    • 8.2.5. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. North America: Country Analysis
    • 8.4.1. United States Self-monitoring Blood Glucose Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Type
        • 8.4.1.2.2. By Frequency
        • 8.4.1.2.3. By Product
        • 8.4.1.2.4. By End-User
    • 8.4.2. Mexico Self-monitoring Blood Glucose Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Type
        • 8.4.2.2.2. By Frequency
        • 8.4.2.2.3. By Product
        • 8.4.2.2.4. By End-User
    • 8.4.3. Canada Self-monitoring Blood Glucose Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Type
        • 8.4.3.2.2. By Frequency
        • 8.4.3.2.3. By Product
        • 8.4.3.2.4. By End-User

9. South America Self-monitoring Blood Glucose Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Frequency
    • 9.2.3. By Product
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. South America: Country Analysis
    • 9.4.1. Brazil Self-monitoring Blood Glucose Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Type
        • 9.4.1.2.2. By Frequency
        • 9.4.1.2.3. By Product
        • 9.4.1.2.4. By End-User
    • 9.4.2. Argentina Self-monitoring Blood Glucose Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Type
        • 9.4.2.2.2. By Frequency
        • 9.4.2.2.3. By Product
        • 9.4.2.2.4. By End-User
    • 9.4.3. Colombia Self-monitoring Blood Glucose Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Type
        • 9.4.3.2.2. By Frequency
        • 9.4.3.2.3. By Product
        • 9.4.3.2.4. By End-User

10. Middle East and Africa Self-monitoring Blood Glucose Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Frequency
    • 10.2.3. By Product
    • 10.2.4. By End-User
    • 10.2.5. By Country
  • 10.3. Market Attractiveness Index
  • 10.4. MEA: Country Analysis
    • 10.4.1. South Africa Self-monitoring Blood Glucose Market Outlook
      • 10.4.1.1. Market Size & Forecast
        • 10.4.1.1.1. By Value
      • 10.4.1.2. Market Share & Forecast
        • 10.4.1.2.1. By Type
        • 10.4.1.2.2. By Frequency
        • 10.4.1.2.3. By Product
        • 10.4.1.2.4. By End-User
    • 10.4.2. Saudi Arabia Self-monitoring Blood Glucose Market Outlook
      • 10.4.2.1. Market Size & Forecast
        • 10.4.2.1.1. By Value
      • 10.4.2.2. Market Share & Forecast
        • 10.4.2.2.1. By Type
        • 10.4.2.2.2. By Frequency
        • 10.4.2.2.3. By Product
        • 10.4.2.2.4. By End-User
    • 10.4.3. UAE Self-monitoring Blood Glucose Market Outlook
      • 10.4.3.1. Market Size & Forecast
        • 10.4.3.1.1. By Value
      • 10.4.3.2. Market Share & Forecast
        • 10.4.3.2.1. By Type
        • 10.4.3.2.2. By Frequency
        • 10.4.3.2.3. By Product
        • 10.4.3.2.4. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Competition Outlook
  • 13.2. Players Profiled (Leading Companies)
    • 13.2.1. PHC Holdings Corporation
    • 13.2.2. Roche
    • 13.2.3. LifeScan
    • 13.2.4. Arkray
    • 13.2.5. Ascensia Diabetes Care
    • 13.2.6. Agamatrix
    • 13.2.7. Bionime Corporation
    • 13.2.8. Sanofi
    • 13.2.9. Dexcom
    • 13.2.10. Medtronic
    • 13.2.11. Nipro Diagnostics
    • 13.2.12. B. Braun
    • 13.2.13. Becton Dickinson
    • 13.2.14. Trividia Health
    • 13.2.15. Rossmax
    • 13.2.16. Allmedicus
    • 13.2.17. Nova Biomedical
    • 13.2.18. Sinocare
    • 13.2.19. Morepen Laboratories
    • 13.2.20. I-Sens

14. Strategic Recommendations

15. About Us & Disclaimer